At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ITP IT Tech Packaging Inc
Trading 12-17 13:47:08 EST
0.2380
-0.0050
-2.06%
High0.2409Low0.2355Vol65.68K
Open0.2396D1 Closing0.2430Amplitude2.22%
Mkt Cap4.04MTradable Cap3.91MTotal Shares16.97M
T/O15.73KT/O Rate0.40%Tradable Shares16.42M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
GlobeNewswire  ·  12-15 14:00
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
GlobeNewswire  ·  12-09
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
GlobeNewswire  ·  12-03
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
GlobeNewswire  ·  11-25
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
Press Release: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
Dow Jones  ·  11-14
Press Release: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
GlobeNewswire  ·  11-06
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire  ·  11-06
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
GlobeNewswire  ·  11-03
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
IT Tech Packaging Inc. held annual shareholder meeting
Reuters  ·  11-01
IT Tech Packaging Inc. held annual shareholder meeting
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire  ·  10-30
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
GlobeNewswire  ·  10-29
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance
GlobeNewswire  ·  10-28
Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance
Climb Bio’s Promising ITP Study: A Potential Game-Changer for Investors
TIPRANKS  ·  10-28
Climb Bio’s Promising ITP Study: A Potential Game-Changer for Investors
Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting
GlobeNewswire  ·  10-23
Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
GlobeNewswire  ·  10-17
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
Bionano to Participate in the H.C. Wainwright @ Home Event
GlobeNewswire  ·  10-07
Bionano to Participate in the H.C. Wainwright @ Home Event
Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering
GlobeNewswire  ·  09-16
Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering
Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology
GlobeNewswire  ·  09-16
Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology
CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders
GlobeNewswire  ·  09-15
CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders
BRIEF-It Tech Packaging Inc - No Material Development Or Reason For Unusual Market Action
Reuters  ·  09-11
BRIEF-It Tech Packaging Inc - No Material Development Or Reason For Unusual Market Action
No data available

Introduction

Company Name.
IT Tech Packaging Inc
Affiliated Markets:
AMEX
Listing Date:
--
Main Business:
IT Tech Packaging, Inc., together with its subsidiaries, engages in the production and distribution of paper products in the People's Republic of China. The company operates through three segments: Dongfang Paper, Tengsheng Paper, and Baoding Shengde. It offers corrugating medium papers to companies making corrugating cardboards; and offset printing papers to printing companies. The company also provides tissue paper products, including toilet papers, boxed and soft-packed tissues, handkerchief tissues, and paper napkins, as well as bathroom and kitchen paper towels under the Dongfang Paper brand. In addition, it produces and sells non-medical single-use face masks, and medical face masks. The company was formerly known as Orient Paper, Inc. and changed its name to IT Tech Packaging, Inc. in August 2018. The company is headquartered in Baoding, the People's' Republic of China.
Issue price:
--